23andMe Bankruptcy Filing May Put Sensitive Data at Risk

23andMe has entered voluntary Chapter 11 bankruptcy, prompting regulators and security experts to warn that the company's highly sensitive genetic dataset—already impacted by a prior credential-stuffing breach—could be sold, mishandled, or exfiltrated during asset-sale or wind-down processes; experts urge customers to review research consent settings and consider deleting data, and call for stronger sector-specific protections for genetic information.